The Troubling Reality of Wilderness Therapy
Scholars claim that unregulated wilderness therapy programs fail to protect the children participants.
Patient Versus Algorithm
Scholars propose enabling patients to sue the makers and providers of discriminatory health care algorithms.
Are Older Adults Being Protected?
Experts offer analysis and policy ideas to promote the independence and well-being of older adults.
The Troubled Teen Industry’s Troubling Lack of Oversight
The federal government must step in to regulate an industry fraught with youth abuse.
Bringing Professional Regulation Into the Future
Ireland’s Chief Nursing Officer endorses a flexible and compassionate approach to health care regulation.
A New Balance Between Health Care Privacy and Artificial Intelligence
A scholar highlights problematic ways that artificial intelligence and health privacy interact.
Cracking Down on Overdose Deaths
FDA approves first over-the-counter treatment to combat the opioid overdose epidemic.
Patent Law Could Also Limit Mifepristone Access
Existing patents deter the marketing of more affordable generic drugs that could be used off-label for abortions.
FDA’s Role in Access to Reproductive Health Care
Recent abortion pill litigation underscores the significance of calls to make birth control pills available over the counter.
Bettering Behavioral Health
Scholars examine regulatory solutions for improving behavioral health care.
Regulating to Improve Methadone Access
Scholars identify avenues to curb regulatory barriers to substitution therapy.
Sugar, Spice, Are Additives Nice?
Scholar argues that loopholes in U.S. food regulation put consumers at risk.